Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial
Lists
Only you see this
Abstract
These findings suggest that smoking cessation and drinking reduction can be concomitantly targeted with pharmacotherapy and that while varenicline alone may be sufficient as a smoking cessation aid in heavy-drinking smokers, the combination of varenicline and naltrexone may confer benefits with regard to drinking outcomes, particularly during the 12-week period of active medication treatment.
BibTeX
@inproceedings{ray2021efficacy,
author = {Lara A. Ray and ReJoyce Green and Craig K. Enders and Adam M. Leventhal and Erica N. Grodin and Gang Li and Aaron C. Lim and Emily E. Hartwell and Alex Venegas and Lindsay R. Meredith and Steven J. Nieto and Steven Shoptaw and Diana Ho and Karen Miotto},
title = {{Efficacy of Combining Varenicline and Naltrexone for Smoking Cessation and Drinking Reduction: A Randomized Clinical Trial}},
booktitle = {American},
year = {2021},
doi = {10.1176/appi.ajp.2020.20070993},
}Loading related content...